Effects of high-intensity interval exercise on arterial stiffness in individuals at risk for cardiovascular disease: a meta-analysis.

Ping Luo, Ruoshan Wu, Weifeng Gao, Weiyi Yan, Ruixue Wang, Yufang Ye
Author Information
  1. Ping Luo: School of Physical Education, Wuhan Sport University, Wuhan, China.
  2. Ruoshan Wu: School of Physical Education, Hunan University of Science and Technology, Xiangtan, China.
  3. Weifeng Gao: School of Physical Education, Wuhan Sport University, Wuhan, China.
  4. Weiyi Yan: School of Physical Education, Wuhan Sport University, Wuhan, China.
  5. Ruixue Wang: School of Physical Education, Wuhan Sport University, Wuhan, China.
  6. Yufang Ye: School of Physical Education, Wuhan Sport University, Wuhan, China.

Abstract

Objective: The purpose of this meta-analysis was to investigate the effect of high-intensity interval training (HIIT) on arterial stiffness (AS) and vascular function in persons at high risk of cardiovascular disease (CVD).
Methods: We conducted a comprehensive search of randomized controlled trials (RCTs) published in electronic databases (PubMed, Web of Science, Cochrane, Embase, and Ebsco) since their inception through October 2023 to evaluate the effect of HIIT on AS and vascular function in persons at high risk for CVD. The weighted mean difference (WMD) and 95% confidence intervals (95% CI) were calculated, and heterogeneity was assessed using the test.
Results: This study included 661 participants from 16 studies. HIIT significantly reduced pulse wave velocity (PWV) in persons at high risk for CVD [weighted mean difference (WMD), -0.62; 95% CI, -0.86--0.38; ���<���0.00001]. Subgroup analysis showed that the PWV improvement effect was better when the HIIT program was performed 2-3 times per week and the duration was controlled within 40���min [2-3 times, -0.67; 95% CI, -0.93--0.41; ���<���0.00001; time of duration, ���40���min, -0.66; 95% CI, -0.91--0.41; ���<���0.00001]. HIIT significantly reduced systolic blood pressure (SBP, -5.43; 95% CI, -8.82--2.04; ���=���0.002), diastolic blood pressure (DPB, -2.96; 95% CI, -4.88--1.04; ���=���0.002), and resting heart rate (RHR, -4.35; 95% CI, -7.04--1.66; ���=���0.002), but had no significant effect on augmentation index (AIX, -2.14; 95% CI, -6.77-2.50; ���=���0.37).
Conclusion: HIIT can improve PWV in high-risk individuals with CVD and reduce SBP, DBP, and RHR, but has no significant effect on AIX. HIIT can effectively improve AS and vascular function and can be recommended as an effective method to improve AS in high-risk persons with CVD.
Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier: CRD42023471593.

Keywords

References

  1. J Am Coll Cardiol. 2013 Aug 13;62(7):584-92 [PMID: 23665370]
  2. Int J Sports Physiol Perform. 2013 Nov;8(6):600-10 [PMID: 23799827]
  3. BMC Pediatr. 2022 Mar 1;22(1):112 [PMID: 35232402]
  4. Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):554-66 [PMID: 12615661]
  5. J Am Coll Cardiol. 2011 Apr 5;57(14):1511-22 [PMID: 21453829]
  6. Hypertens Res. 2010 Aug;33(8):836-43 [PMID: 20448634]
  7. Int J Cardiol. 2017 Dec 1;248:314-319 [PMID: 28716522]
  8. Am J Kidney Dis. 2015 Aug;66(2):285-96 [PMID: 25960303]
  9. Diabetes Care. 2003 Aug;26(8):2442-50 [PMID: 12882876]
  10. Am J Cardiol. 2010 Apr 1;105(7):905-11 [PMID: 20346304]
  11. J Sci Med Sport. 2019 Apr;22(4):385-391 [PMID: 30803498]
  12. Eur J Appl Physiol. 2021 Jul;121(7):1967-1978 [PMID: 33778908]
  13. J Cardiopulm Rehabil Prev. 2019 Jan;39(1):50-55 [PMID: 30586113]
  14. Eur J Sport Sci. 2015;15(5):443-57 [PMID: 25251989]
  15. Sports Med. 2015 May;45(5):679-92 [PMID: 25771785]
  16. Medicine (Baltimore). 2020 Mar;99(10):e19471 [PMID: 32150108]
  17. J Hypertens. 2021 Feb 1;39(2):214-222 [PMID: 32833924]
  18. BMJ. 2009 Jul 21;339:b2700 [PMID: 19622552]
  19. Eur Heart J. 2010 Sep;31(18):2271-9 [PMID: 20601389]
  20. Front Cardiovasc Med. 2022 Aug 18;9:960096 [PMID: 36061566]
  21. Int J Cardiol. 2020 Dec 1;320:148-154 [PMID: 32598997]
  22. Eur J Pediatr. 2022 Jul;181(7):2633-2642 [PMID: 35499629]
  23. Eur Heart J. 2005 May;26(10):967-74 [PMID: 15774493]
  24. Scand J Med Sci Sports. 2020 Feb;30(2):312-321 [PMID: 31603262]
  25. J Physiol. 2004 Nov 15;561(Pt 1):1-25 [PMID: 15375191]
  26. Curr Hypertens Rep. 2020 Mar 3;22(3):26 [PMID: 32125550]
  27. Med Sci Sports Exerc. 2017 Jul;49(7):1404-1411 [PMID: 28166118]
  28. Cardiovasc Res. 2005 May 1;66(2):393-401 [PMID: 15820208]
  29. Hypertens Res. 2010 Jun;33(6):627-32 [PMID: 20379194]
  30. Hypertension. 1990 Apr;15(4):339-47 [PMID: 2180816]
  31. Cardiovasc Ther. 2008 Fall;26(3):214-23 [PMID: 18786091]
  32. Diabetologia. 2017 Jan;60(1):7-23 [PMID: 27681241]
  33. Br J Sports Med. 2013 Apr;47(6):393-6 [PMID: 22267567]
  34. Gerontology. 2012;58(3):227-37 [PMID: 22222677]
  35. Nutrients. 2020 Dec 30;13(1): [PMID: 33396889]
  36. Adv Physiol Educ. 2014 Dec;38(4):296-307 [PMID: 25434012]
  37. Am J Hypertens. 2013 Sep;26(9):1093-102 [PMID: 23736111]
  38. Eur J Cardiovasc Prev Rehabil. 2008 Jun;15(3):239-46 [PMID: 18525377]
  39. Ugeskr Laeger. 2007 Jun 18;169(25):2442-5 [PMID: 17594841]
  40. J Hum Hypertens. 2009 Jul;23(7):470-8 [PMID: 19092847]
  41. Int J Cardiol. 2014 May 15;173(3):361-8 [PMID: 24698257]
  42. J Strength Cond Res. 2021 Jan 1;35(1):275-279 [PMID: 29927896]
  43. Atherosclerosis. 2011 Sep;218(1):90-5 [PMID: 21605864]
  44. Front Physiol. 2017 Dec 19;8:1086 [PMID: 29311997]
  45. J Hypertens. 2020 Feb;38(2):243-248 [PMID: 31917375]
  46. Diabet Med. 2012 Sep;29(9):1119-25 [PMID: 22364114]
  47. Circulation. 2007 Nov 6;116(19):2110-8 [PMID: 17967770]
  48. J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27 [PMID: 20338492]
  49. J Clin Hypertens (Greenwich). 2018 Jan;20(1):11-18 [PMID: 29106772]
  50. J Exerc Sci Fit. 2023 Oct;21(4):313-325 [PMID: 37520931]
  51. Front Physiol. 2019 Sep 04;10:1119 [PMID: 31551805]
  52. Obes Rev. 2024 Mar;25(3):e13666 [PMID: 38031812]
  53. Cardiovasc Diabetol. 2011 Jan 28;10:12 [PMID: 21276212]
  54. Int J Cardiol. 2015 Jan 20;179:269-74 [PMID: 25464463]
  55. Arch Intern Med. 1995 Apr 10;155(7):701-9 [PMID: 7695458]
  56. Child Obes. 2018 Jan;14(1):41-49 [PMID: 29099231]
  57. Arch Gerontol Geriatr. 2019 May - Jun;82:217-225 [PMID: 30844623]
  58. Am Heart J. 2010 Apr;159(4):612-619.e3 [PMID: 20362720]
  59. Antioxidants (Basel). 2020 Mar 07;9(3): [PMID: 32156043]
  60. PLoS One. 2014 Oct 15;9(10):e110034 [PMID: 25333969]
  61. Eur Rev Med Pharmacol Sci. 2023 May;27(9):4069-4079 [PMID: 37203832]
  62. Circ Res. 2015 Jul 3;117(2):207-19 [PMID: 26139859]
  63. Yonsei Med J. 2012 Mar;53(2):258-61 [PMID: 22318811]
  64. Circulation. 2001 Oct 2;104(14):1627-32 [PMID: 11581140]
  65. Eur Heart J. 2010 Aug;31(15):1865-71 [PMID: 20197424]
  66. J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):102-8 [PMID: 15526244]
  67. PLoS Med. 2013;10(6):e1001465 [PMID: 23776415]
  68. Ann Intern Med. 2002 Apr 2;136(7):493-503 [PMID: 11926784]
  69. Sports Med Open. 2021 Jul 19;7(1):49 [PMID: 34279765]
  70. Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):163-171 [PMID: 30227187]
  71. Circulation. 2004 Nov 2;110(18):2858-63 [PMID: 15492301]
  72. J Am Coll Cardiol. 2014 Feb 25;63(7):636-646 [PMID: 24239664]
  73. Med Sci (Basel). 2018 Oct 30;6(4): [PMID: 30380802]
  74. J Hum Hypertens. 2006 May;20(5):348-54 [PMID: 16496019]
  75. Sports Med. 2018 Sep;48(9):2127-2142 [PMID: 29949110]
  76. Ann Med. 2000 Sep;32(6):383-5 [PMID: 11028684]
  77. Diabetes Metab. 2008 Feb;34(1):2-11 [PMID: 18093861]
  78. Eur Heart J. 2006 Nov;27(21):2588-605 [PMID: 17000623]
  79. Circulation. 2010 Feb 2;121(4):505-11 [PMID: 20083680]
  80. Circulation. 2007 Aug 28;116(9):1081-93 [PMID: 17671237]
  81. PLoS One. 2018 Jul 23;13(7):e0200829 [PMID: 30036390]
  82. Sports Med. 2018 Dec;48(12):2785-2795 [PMID: 30357656]
  83. Endocrinology. 2004 Dec;145(12):5589-97 [PMID: 15319349]

Word Cloud

Created with Highcharts 10.0.095%CIHIIT-0effectCVDASpersonsriskbloodpressure���=���0high-intensityintervalarterialstiffnessvascularfunctionhighcardiovascularPWV���<���0002canimprovemeta-analysisdiseasecontrolledmeandifferenceWMDsignificantlyreducedpulsewavevelocity00001]timesduration4166systolicSBP04diastolic-2-4restingheartrateRHRsignificantaugmentationindexAIXhigh-riskindividualsexerciseObjective:purposeinvestigatetrainingMethods:conductedcomprehensivesearchrandomizedtrialsRCTspublishedelectronicdatabasesPubMedWebScienceCochraneEmbaseEbscosinceinceptionOctober2023evaluateweightedconfidenceintervalscalculatedheterogeneityassessedusingtestResults:studyincluded661participants16studies[weighted6286--038Subgroupanalysisshowedimprovementbetterprogramperformed2-3perweekwithin40���min[2-36793--000001time���40���min91--0-543-882--2DPB9688--135-704--114-677-25037Conclusion:reduceDBPeffectivelyrecommendedeffectivemethodSystematicReviewRegistration:https://wwwcrdyorkacuk/PROSPERO/identifier:CRD42023471593Effectsdisease:

Similar Articles

Cited By